Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

EAN/ERS/ESO/ESRS statement on the impact of sleep disorders on risk and outcome of stroke

Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

Harvard

Bassetti, CLA, Randerath, W, Vignatelli, L, Ferini-Strambi, L, Brill, A-K, Bonsignore, MR, Grote, L, Jennum, P, Leys, D, Minnerup, J, Nobili, L, Tonia, T, Morgan, R, Kerry, J, Riha, R, McNicholas, WT & Papavasileiou, V 2020, 'EAN/ERS/ESO/ESRS statement on the impact of sleep disorders on risk and outcome of stroke', European Respiratory Journal. Supplement, bind 55, nr. 4, 1901104, s. 1901104. https://doi.org/10.1183/13993003.01104-2019

APA

Bassetti, C. L. A., Randerath, W., Vignatelli, L., Ferini-Strambi, L., Brill, A-K., Bonsignore, M. R., Grote, L., Jennum, P., Leys, D., Minnerup, J., Nobili, L., Tonia, T., Morgan, R., Kerry, J., Riha, R., McNicholas, W. T., & Papavasileiou, V. (2020). EAN/ERS/ESO/ESRS statement on the impact of sleep disorders on risk and outcome of stroke. European Respiratory Journal. Supplement, 55(4), 1901104. [1901104]. https://doi.org/10.1183/13993003.01104-2019

CBE

Bassetti CLA, Randerath W, Vignatelli L, Ferini-Strambi L, Brill A-K, Bonsignore MR, Grote L, Jennum P, Leys D, Minnerup J, Nobili L, Tonia T, Morgan R, Kerry J, Riha R, McNicholas WT, Papavasileiou V. 2020. EAN/ERS/ESO/ESRS statement on the impact of sleep disorders on risk and outcome of stroke. European Respiratory Journal. Supplement. 55(4):1901104. https://doi.org/10.1183/13993003.01104-2019

MLA

Vancouver

Bassetti CLA, Randerath W, Vignatelli L, Ferini-Strambi L, Brill A-K, Bonsignore MR o.a. EAN/ERS/ESO/ESRS statement on the impact of sleep disorders on risk and outcome of stroke. European Respiratory Journal. Supplement. 2020 apr.;55(4):1901104. 1901104. https://doi.org/10.1183/13993003.01104-2019

Author

Bassetti, Claudio L A ; Randerath, Winfried ; Vignatelli, Luca ; Ferini-Strambi, Luigi ; Brill, Anne-Kathrin ; Bonsignore, Maria R ; Grote, Ludger ; Jennum, Poul ; Leys, Didier ; Minnerup, Jens ; Nobili, Lino ; Tonia, Thomy ; Morgan, Rebecca ; Kerry, Joel ; Riha, Renata ; McNicholas, Walter T ; Papavasileiou, Vasileios. / EAN/ERS/ESO/ESRS statement on the impact of sleep disorders on risk and outcome of stroke. I: European Respiratory Journal. Supplement. 2020 ; Bind 55, Nr. 4. s. 1901104.

Bibtex

@article{680f0f67a2934838957c35591df69b43,
title = "EAN/ERS/ESO/ESRS statement on the impact of sleep disorders on risk and outcome of stroke",
abstract = "Sleep disorders are highly prevalent in the general population and may be linked in a bidirectional fashion to stroke, which is one of the leading causes of morbidity and mortality.Four major scientific societies established a task force of experts in neurology, stroke, respiratory medicine, sleep medicine and methodology, to critically evaluate the evidence regarding potential links and the impact of therapy. 13 research questions were evaluated in a systematic literature search using a stepwise hierarchical approach: first, systematic reviews and meta-analyses; second, primary studies post-dating the systematic reviews/meta-analyses. A total of 445 studies were evaluated and 88 included. Statements were generated regarding current evidence and clinical practice.Severe obstructive sleep apnoea (OSA) doubles the risk for incident stroke, especially in young to middle-aged patients. Continuous positive airway pressure (CPAP) may reduce stroke risk, especially in treatment-compliant patients. The prevalence of OSA is high in stroke patients and can be assessed by polygraphy. Severe OSA is a risk factor for recurrence of stroke and may be associated with stroke mortality, while CPAP may improve stroke outcome. It is not clear if insomnia increases stroke risk, while pharmacotherapy of insomnia may increase it. Periodic limb movements in sleep (PLMS), but not restless limb syndrome (RLS), may be associated with an increased risk of stroke. Preliminary data suggest a high frequency of post-stroke insomnia and RLS and their association with a less favourable stroke outcome, while treatment data are scarce.Overall, the evidence base is best for OSA relationship with stroke and supports active diagnosis and therapy. Research gaps remain especially regarding insomnia and RLS/PLMS relationships with stroke.",
author = "Bassetti, {Claudio L A} and Winfried Randerath and Luca Vignatelli and Luigi Ferini-Strambi and Anne-Kathrin Brill and Bonsignore, {Maria R} and Ludger Grote and Poul Jennum and Didier Leys and Jens Minnerup and Lino Nobili and Thomy Tonia and Rebecca Morgan and Joel Kerry and Renata Riha and McNicholas, {Walter T} and Vasileios Papavasileiou",
note = "The article has been co‐published with permission in the European Respiratory Journal and the European Journal of Neurology. The articles are identical except for minor stylistic and spelling differences in keeping with each journal's style. Either citation can be used when citing this article. Copyright {\textcopyright}European Academy of Neurology and European Respiratory Society 2020.",
year = "2020",
month = apr,
doi = "10.1183/13993003.01104-2019",
language = "English",
volume = "55",
pages = "1901104",
journal = "European Respiratory Journal. Supplement",
issn = "0904-1850",
publisher = "European Respiratory Society",
number = "4",

}

RIS

TY - JOUR

T1 - EAN/ERS/ESO/ESRS statement on the impact of sleep disorders on risk and outcome of stroke

AU - Bassetti, Claudio L A

AU - Randerath, Winfried

AU - Vignatelli, Luca

AU - Ferini-Strambi, Luigi

AU - Brill, Anne-Kathrin

AU - Bonsignore, Maria R

AU - Grote, Ludger

AU - Jennum, Poul

AU - Leys, Didier

AU - Minnerup, Jens

AU - Nobili, Lino

AU - Tonia, Thomy

AU - Morgan, Rebecca

AU - Kerry, Joel

AU - Riha, Renata

AU - McNicholas, Walter T

AU - Papavasileiou, Vasileios

N1 - The article has been co‐published with permission in the European Respiratory Journal and the European Journal of Neurology. The articles are identical except for minor stylistic and spelling differences in keeping with each journal's style. Either citation can be used when citing this article. Copyright ©European Academy of Neurology and European Respiratory Society 2020.

PY - 2020/4

Y1 - 2020/4

N2 - Sleep disorders are highly prevalent in the general population and may be linked in a bidirectional fashion to stroke, which is one of the leading causes of morbidity and mortality.Four major scientific societies established a task force of experts in neurology, stroke, respiratory medicine, sleep medicine and methodology, to critically evaluate the evidence regarding potential links and the impact of therapy. 13 research questions were evaluated in a systematic literature search using a stepwise hierarchical approach: first, systematic reviews and meta-analyses; second, primary studies post-dating the systematic reviews/meta-analyses. A total of 445 studies were evaluated and 88 included. Statements were generated regarding current evidence and clinical practice.Severe obstructive sleep apnoea (OSA) doubles the risk for incident stroke, especially in young to middle-aged patients. Continuous positive airway pressure (CPAP) may reduce stroke risk, especially in treatment-compliant patients. The prevalence of OSA is high in stroke patients and can be assessed by polygraphy. Severe OSA is a risk factor for recurrence of stroke and may be associated with stroke mortality, while CPAP may improve stroke outcome. It is not clear if insomnia increases stroke risk, while pharmacotherapy of insomnia may increase it. Periodic limb movements in sleep (PLMS), but not restless limb syndrome (RLS), may be associated with an increased risk of stroke. Preliminary data suggest a high frequency of post-stroke insomnia and RLS and their association with a less favourable stroke outcome, while treatment data are scarce.Overall, the evidence base is best for OSA relationship with stroke and supports active diagnosis and therapy. Research gaps remain especially regarding insomnia and RLS/PLMS relationships with stroke.

AB - Sleep disorders are highly prevalent in the general population and may be linked in a bidirectional fashion to stroke, which is one of the leading causes of morbidity and mortality.Four major scientific societies established a task force of experts in neurology, stroke, respiratory medicine, sleep medicine and methodology, to critically evaluate the evidence regarding potential links and the impact of therapy. 13 research questions were evaluated in a systematic literature search using a stepwise hierarchical approach: first, systematic reviews and meta-analyses; second, primary studies post-dating the systematic reviews/meta-analyses. A total of 445 studies were evaluated and 88 included. Statements were generated regarding current evidence and clinical practice.Severe obstructive sleep apnoea (OSA) doubles the risk for incident stroke, especially in young to middle-aged patients. Continuous positive airway pressure (CPAP) may reduce stroke risk, especially in treatment-compliant patients. The prevalence of OSA is high in stroke patients and can be assessed by polygraphy. Severe OSA is a risk factor for recurrence of stroke and may be associated with stroke mortality, while CPAP may improve stroke outcome. It is not clear if insomnia increases stroke risk, while pharmacotherapy of insomnia may increase it. Periodic limb movements in sleep (PLMS), but not restless limb syndrome (RLS), may be associated with an increased risk of stroke. Preliminary data suggest a high frequency of post-stroke insomnia and RLS and their association with a less favourable stroke outcome, while treatment data are scarce.Overall, the evidence base is best for OSA relationship with stroke and supports active diagnosis and therapy. Research gaps remain especially regarding insomnia and RLS/PLMS relationships with stroke.

UR - http://www.scopus.com/inward/record.url?scp=85083871842&partnerID=8YFLogxK

U2 - 10.1183/13993003.01104-2019

DO - 10.1183/13993003.01104-2019

M3 - Journal article

C2 - 32317355

VL - 55

SP - 1901104

JO - European Respiratory Journal. Supplement

JF - European Respiratory Journal. Supplement

SN - 0904-1850

IS - 4

M1 - 1901104

ER -

ID: 61830676